OLYMPIA, WA - Costly prescription drugs could become available to Washingtonians in the form of far less expensive generic products, thanks to…
Search / 548 results found Showing: 1-10 of 548
NEW YORK (AP) — Children ages 12 and older can now roll up their sleeves for COVID-19 vaccines in the U.S., offering parents and schools a cha…
SEATTLE, May 10, 2021 /PRNewswire/ -- The Infectious Disease Research Institute (IDRI), Duke Human Vaccine Institute, and 3M have collaborated to create a vaccine candidate with potential to provide protection against multiple variants of SARS-CoV-2, as well as other coronaviruses. Study results published in the May 10th edition of Nature show the vaccine candidate, which combines a nanoparticle developed by a Duke-led research team with the IDRI's novel formulation of 3M's "3M-052" compound, stimulates increased levels of production of "broadly neutralizing antibodies" against several strains of coronavirus, including bat coronaviruses.
Questions are raised about Deacon Mark and an anonymous call gives Dawn hope that Katie might still be alive.
BELLEVUE, Wash., May 6, 2021 /PRNewswire/ -- Viome, a mission-driven bioscience company focused on helping individuals improve their health, today announced its proprietary mRNA analysis technology combined with its next-generation AI platform has been designated a Breakthrough Device by The Food and Drug Administration (FDA) for early detection of oral cancer and throat cancer.
(The Center Square) – More than 100 colleges across the U.S. have said they will require students to receive a COVID-19 vaccine in order to attend in-person classes.
WASHINGTON, May 3, 2021 /PRNewswire/ -- The Microbiome Therapeutics Innovation Group (MTIG) announced today the addition of Norwegian molecular diagnostic company Genetic Analysis AS to its coalition of companies leading the research and development of FDA-approved microbiome therapeutic drugs and microbiome-based products.